NEW YORK: An influential consumer advocacy group is pressing Pfizer to supply more of its new COVID-19 pill Paxlovid to developing countries this year, concerned that access to the treatment will mirror inequalities in vaccines. Public Citizen sent a letter to Pfizer chief executive Albert Bourla on M